Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis

International Journal of Biological Markers

Volumn 16, Issue 1, 2001, Pages 62-68

  Pacheco, M M ^a   Nishimoto, I N ^a   Mourao Neto M ^a   Mantovani, E B ^a   Brentani, M M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast neoplasms; Metalloproteinases; Serine proteinases; Survival analysis

Indexed keywords

BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; FLUOROURACIL; GELATINASE B; MESSENGER RNA; METHOTREXATE; TAMOXIFEN; UROKINASE; UROKINASE RECEPTOR;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; CANCER SURVIVAL; CANCER TISSUE; FEMALE; FOLLOW UP; GENETIC TRANSCRIPTION; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIVARIATE ANALYSIS; NORTHERN BLOTTING; PROBABILITY; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 0035077647     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080101600109     Document Type: Article

References (35)

1. The urokinase-type plasminogen activator system in cancer metastasis: A review
2. Matrix metalloproteinases: Multifunctional contributors to tumor progression
3. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients
4. Activity of type IV collagenases in benign and malignant breast tissue disease
5. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence
6. Assay of matrix metalloproteinases types 8 and 9 by ELISA in human breast cancer
7. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
8. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans
9. Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer
10. Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: Clinico-pathological correlations
11. Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression
12. High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases
13. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer
14. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas
15. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas
16. Proteolysis in human breast and colorectal cancer
17. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors
18. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells
19. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion
20. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell bound reactants
21. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay
22. SV-40-transformed human lung fibroblasts secrete a 92-kDa collagenase, which is identical to that secreted by normal human macrophages
23. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy
24. Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA
25. Characterization of mouse ribosomal gene fragments purified by molecular cloning
26. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
27. A technique for radiolabeling DNA restriction endonuclease fragments to high specificity activity
28. Plasminogen activator expression and steroid hormone receptors in female breast cancer: A multifactorial study
29. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signalling cascades
30. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signalling cascade
31. Secretion of urokinase and metalloproteinase-9 induced by staurosporine is dependent on a tyrosine kinase pathway in mammary tumor cells
32. Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells
33. Expression of a novel factor, com1, in early tumor progression of breast cancer
34. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer
35. Urokinase plasminogen activator receptor in breast cancer